We are live on ! Find out more
AONC

American Oncology Network, Inc. Class A Common Stock

Delisted

AONC was delisted on the 7th of June, 2024.

2 hedge funds and large institutions have $25.8K invested in American Oncology Network, Inc. Class A Common Stock in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% less funds holding

Funds holding: 102 (-8)

80% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 10

95% less capital invested

Capital invested by funds: $547K → $25.8K (-$521K)

Holders
2
Holders Change
-8
Holders Change %
-80%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
DT
1
Diversified Trust
Tennessee
$22.7K +$83.1K +21,618 New
IA
2
IFP Advisors
Florida
$3.15K +$11.5K +3,000 New
AC
3
Applied Capital
Arkansas
-$206K -37,499 Closed
Geode Capital Management
4
Geode Capital Management
Massachusetts
-$125K -22,687 Closed
BW
5
BIP Wealth
Georgia
-$97.7K -17,791 Closed
TSS
6
Two Sigma Securities
New York
-$57.8K -10,535 Closed
Qube Research & Technologies (QRT)
7
Qube Research & Technologies (QRT)
United Kingdom
-$31.1K -5,663 Closed
UBS Group
8
UBS Group
Switzerland
-$18.4K -3,351 Closed
Morgan Stanley
9
Morgan Stanley
New York
-$7.87K -1,433 Closed
CFFP
10
Center for Financial Planning
Michigan
-$1.83K -334 Closed
TRCT
11
Tower Research Capital (TRC)
New York
-$1.69K -307 Closed
Wells Fargo
12
Wells Fargo
California
-$60 -11 Closed

AONC Hedge Fund Activity: Q2 2024 in Review

2 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in American Oncology Network, Inc. Class A Common Stock (AONC) for Q2 2024, worth a combined $25.8K — down 95% from $547K a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of AONC and 2 opened new positions — a net loss of 8 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Diversified Trust, opening a new position worth an estimated $83.1K. The largest seller was Applied Capital, exiting entirely with an estimated $206K sold.

  • 2 institutional investors held American Oncology Network, Inc. Class A Common Stock (AONC) as of Q2 2024, down from 10 in Q1 2024.
  • Funds reported $25.8K of American Oncology Network, Inc. Class A Common Stock stock for Q2 2024, down 95% quarter-over-quarter.
  • 2 funds opened new American Oncology Network, Inc. Class A Common Stock positions in Q2 2024 and 10 closed out, a net change of -8 holders.
  • The largest American Oncology Network, Inc. Class A Common Stock buyer in Q2 2024 was Diversified Trust, an estimated $83.1K added.
  • The largest American Oncology Network, Inc. Class A Common Stock seller in Q2 2024 was Applied Capital, an estimated $206K sold.

Based on aggregated 13F filings for Q2 2024.